Selective estrogen-receptor modulators for primary prevention of breast cancer.
Fabian
Carol J
CJ
Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. cfabian@kumc.edu
Kimler
Bruce F
BF
D000368:Aged; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017698:Postmenopause; D017697:Premenopause; D011322:Primary Prevention / Q000379:methods*; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011960:Receptors, Estrogen / Q000145:classification / Q000187:drug effects / Q000502:physiology; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride